INTRODUCTION
The fall in the serum levels of streptolysin S inhibitor (SSI) which usually occurs during the acute phase of rheumatic fever (1, 2) suggested a disturbance of lipoprotein metabolism in this disease. Previous studies indicated that the inhibition of this streptococcal hemolysin by serum is associated with alpha and beta lipoproteins rather than with specific antibody (2) (3) (4) (5) . Streptolysin S is inhibited by saline suspensions of phospholipids but not by cholesterol or neutral fats (6, 3) . In addition, a large proportion of the SSI is destroyed by the action of Cl. welchii lecithinase on serum (3) . It therefore seemed possible that variation in SSI might reflect a parallel variation of serum lipoproteins rich in phospholipid.
The present study was undertaken to explore the relationship of serum levels of total phospholipid, lecithin and sphingomyelin to the SSI titer in the sera of patients with various diseases associated with disturbances in lipid metabolism, and in the sera of experimental animals with induced hyperlipemia. The observations reported below indicate that subnormal levels of SSI in the serum of human beings are associated with hypophospholipemia while elevation of SSI titer is encountered in diseases characterized by an increased concentration of serum phospholipids. The present study also indicates that an increase in SSI may be induced in animals rendered hyperlipemic by various methods.
MATERIALS AND METHODS
Clinical material: Sera were obtained from 44 patients with diseases usually associated with either marked elevation or depression of serum phospholipids. The former group included 12 patients suffering from either intrahepatic or extrahepatic biliary obstruction (seven with biliary cirrhosis; three with serum hepatitis; one with a common duct calculus and one with carcinoma of the head of the pancreas); five patients manifesting the nephrotic syndrome; and three patients with hypothyroidism. (8) . Lecithin 
RESULTS
The relationship of phospholipid levels to SSI in the sera of patients uith disturbance of lipid metabolism
Fifty-eight sera obtained from 44 patients were analyzed for SSI and total phospholipid concentrations. Fifty of these sera were further analyzed for lecithin and sphingomyelin levels. The sera were grouped according to their SSI values. Table I shows the mean concentration and the range of values for serum phospholipids at varying levels of SSI.
In general, there appears to be a positive correlation between the concentration of serum phospholipids and the SSI titer. This relationship is best illustrated by the lecithin fraction. It can be noted, however, that the inhibition of streptolysin S by serum is not a simple function of lecithin concentration. At very low levels of serum lecithin the SSI titer falls abruptly while at high lecithin concentrations the rise in SSI tends to level off. It also appears that at normal levels of SSI ) 500600 ?00 Of the group manifesting nephrotic syndrome, four out of five patients showed a rise in SSI corvalues below the normal and five of the eight had values of less than 128 mg. per 100 ml.
One patient with rheumatic fever and one with serum hepatitis afforded the opportunity to follow contrasting changes in serum lecithin by serial bleedings during the course of their respective diseases. The patient with rheumatic fever showed low serum lecithin levels during the acute stage of the disease which gradually rose to normal as rheumatic activity subsided. This was accompanied by a similar change in the SSI titer. The patient with serum hepatitis had a markedly ele- (Figure 3) . Triton A-20 was itself found to inhibit streptolysin S in vitro. However, when the detergent was added to serum this inhibition was not apparent until concentrations of Triton A-20 exceeding 2%o were reached. Although it is improbable that such concentrations of Triton A-20 were ever achieved in vivo with the dosage employed, other methods for the elevation of serum phospholipid were also employed to obviate this possible objection to the significance of the above data.
b) Follouing ligation of the common bile duct: The effect of ligation of the common bile duct on the concentrations of SSI and phospholipids of the serum of four rabbits was observed. Two of the rabbits developed marked hyperphospholipemia and this was associated with a comparable elevation of SSI. The remaining two animals developed only a mild rise in serum phospholipid and showed, correspondingly, but a slight increase in SSI (Figure 4 ). c) Following cholesterol feeding: Feeding cholesterol to four rabbits was also followed by a rise in SSI and serum phospholipids (Table II) . As with the above methods of inducing hyperphospholipemia, the titer of SSI followed variation in phospholipid concentration. Determination of free and total cholesterol was also performed on these sera since it has been observed that there is an increase in the ratio of serum cholesterol to phospholipid in rabbits fed cholesterol, while in rabbits receiving Triton A-20 this ratio may be reversed (10, 11) . Despite the great increase in serum cholesterol observed in these rabbits, the SSI titer was no greater than that found in Triton A-20 treated rabbits at comparable concentrations of serum phospholipid. Therefore it appears that cholesterol levels have little direct influence on the concentration of SSI, an observation which was expected, since saline suspensions of cholesterol fail to inhibit streptolysin S. 0A~T he effect of intraperitoneal injections on the concentrations of SSI and phospholipid in the serum of mice A rise in serum phospholipid may be induced in mice, as well as in rabbits, by the administration of Triton A-20 and here, too, hyperphospholipemia is associated with a rise in SSI titer (Table  III) . The mouse sera, like rabbit sera, became intensely milky as the blood lipids rose. The mice appeared healthy and gained weight during the administration of the detergent. It is apparent that variations in the titer of SSI reflect, in general, similar variations in serum phospholipid concentration. The subnormal levels of SSI encountered in rheumatic fever, and in certain other diseases, are indicative of hypophospholipemia. Conversely, elevations in SSI above normal levels have been found only in hyperphospholipemic sera.
A considerable range of phospholipid concentration may, however, occur at any given titer of SSI and at very high serum concentrations of phospholipid the increase in SSI tends to level off (Figure 1 ). This indicates that the inhibition of streptolysin S by serum is not a simple function of phospholipid concentration. Since the phospholipids of serum probably exist as components of lipoprotein molecules (12, 13) , it is possible that the SSI titer is affected by variations in the physico-chemical composition of these proteins which occur in hyperlipemic states (13) .
The significance of the fall in serum phospholipid which occurs in rheumatic fever is not un- derstood. The concentration of serum cholesterol has also been observed to fall during the acute phase of this disease (14) , and to be lower in patients with rheumatic heart disease than in patients with hypertensive or arteriosclerotic heart disease (15) . Both lipids decrease in concentration in the serum of patients with a variety of acute and chronic infectious diseases (16, 17) . It has been suggested that the fall in the concentration of serum lipids is not a feature of a particular disease process but rather a non-specific metabolic disturbance common to debilitation and malnutrition (18) . While this view appears reasonable, it has not yet been demonstrated that the hypolipemia of infectious diseases is induced by either hyperpyrexia or dietary deficiency alone (15) .
The behavior of lipoproteins in hypolipemic states has not yet been adequately studied. Whether the newer methods for the separation and analysis of alpha and beta lipoproteins (12, 19, 20) will reveal specific differences in the composition of these proteins during hypolipemia remains to be determined.
The non-antigenic properties of streptolysin S have not heretofore provided the opportunity to study the pathogenicity of this toxin during streptococcal infections by classical antibody protection techniques. The induction of hyperlipemia in rabbits and mice affords a method of increasing SSI in these animals and thus potentially offers a unique opportunity to evaluate the role that a normal inhibitor may play as a host defense against a bacterial toxin. The increase in SSI titer is, however, clearly not of the magnitude usually encountered with the appearance of specific antibodies in serum. Studies are in progress to determine whether hyperlipemic animals develop increased resistance to the toxic effects of streptolysin S and to streptococcal infection. 2. Elevated serum levels of SSI are found only in diseases associated with hyperphospholipemia. Conversely, a fall in SSI titer occurs in acute rheumatic fever and other diseases when serum phospholipids fall below normal levels.
3. The induction of hyperphospholipemia in rabbits by repeated intravenous injections of the nonionic detergent, Triton A-20, by ligation of the common bile duct, and by feeding cholesterol results in an elevation of SSI titer. The SSI titer in mice may also be elevated by repeated intraperitoneal injections of Triton A-20.
